Refine by
Cardiovascular Research Articles & Analysis
15 articles found
As a natural inhibitor of pathological mineralization, MGP has attracted significant attention in cardiovascular and skeletal biology research. The development of recombinant MGP protein has enabled researchers to study the molecular mechanisms of calcification control and evaluate therapeutic interventions in a variety of disease contexts. ...
This is where Customized Rabbit Cytokine Assay services come into play, offering tailored solutions to meet specific research needs. Why Rabbit Models? Rabbits are widely used in biomedical research due to their physiological and immunological similarities to humans. They are particularly valuable in studies related to infectious diseases, ...
For instance, fatty acids can be broken down to acetyl-CoA, which enters the cycle, providing a flexible source of energy in various physiological conditions. TCA Cycle Analysis in Research Recent advancements in metabolomics have shed light on the importance of TCA Cycle analysis in various fields of research, including cancer biology, ...
Recent Breakthroughs in Cardiovascular Research 1. The Impact of Plastics on Heart Health A recent study has revealed that chemicals leaching from plastic takeout containers into food can cause significant cardiovascular damage. ...
By thinning mucus, serrapeptase promotes clearer airways and enhances overall respiratory function, benefiting those with chronic respiratory diseases. 4. Cardiovascular Support Emerging research suggests that serrapeptase may have cardiovascular benefits by helping to dissolve fibrin and plaque in blood vessels. This can potentially improve ...
Patients With Periodontal Disease Are 2 Times More Likely To Have Cardiovascular Disease The Research, Science and Therapy Committee of The American Academy of Periodontology (AAP) 1998 reviewed numerous studies and found periodontal disease and gingivitis as potential contributing factors for infective endocarditis (damaged heart valves), ...
Although COVID-19 crisis still looms over us, Cardiovascular Disease (CVD) remains the number one killer and Diabetes continues to be the key comorbidity and contributor to Coronary Artery Disease (CAD). ...
Although post-mortem brains have been frequently reported as the "gold standard" in transcriptomic research for ND and neuropsychiatric abnormalities, the main sources has been mRNA separated from transgenic animal models and, more lately, patient-derived cell lines. ...
In fact, endotoxemia is often associated with the development of obesity, which may predict a higher risk of diabetes and cardiovascular disease. In the study, the researchers measured lipopolysaccharide levels in the blood of more than 11,000 Finnish people, followed by genome-wide association analysis of participants to map the association between their body ...
Researchers reported these findings in 2015, but continued to collect data into July 2016. ...
Monitoring systems have been used most extensively for cardiovascular diseases such as congestive heart failure (CHF) and arrhythmia detection. ...
The data was presented at the 31st Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation. The latest available analysis of the first 31 heart failure patients with functional mitral regurgitation treated with the AccuCinch system at leading heart centers across the United ...
Your three main coronary arteries are responsible for bringing blood to the heart. When they start to become blocked, it can weaken the heart and eventually lead to a heart attack if the blockage isn't addressed and there isn't enough blood supply to the heart. On the left side of the heart, there are two coronary arteries responsible for providing rich blood supply to the heart to ensure it ...
“If the concentration of PM 2.5 were reduced 10 μg/m3, at least 7.67 % of the deaths that produce in the first 24 hours of a serious heart attack would be avoided, it supposes a reduction of 5 deaths in a year”, says Jordi Bañeras, researcher of the Center of Biomedical Investigation in Network of Cardiovascular Diseases (CIBERCV) in the ...
San Francisco, CA –Aelan Cell Technologies, with an international research team, today released a study that reveals that age is a key determining factor in the efficacy of cell-based or pharmacological treatments. ...